Mission Statement Print E-mail
Sunday, 22 June 2008 13:29

The “Zephyr Foundation” is developed to establish a non-profit organization representing all individuals identified as “long-term non-progressor’s” (LTNP’s), Viremic Controllers, and Elite Controllers of HIV who are participating in clinical research studies throughout the international community.

  • Develop a potential list of donors inclusive of individuals, corporations, and charitable organizations for the Foundation.
  • Assist in recruitment efforts by locating and linking eligible participants to the LTNP/HIV Controller research studies for the advancement of those studies.
  • Provide financial resources in support of travel, lodging, meals and incidental expenses associated with participation in LTNP/HIV Controller clinical research studies.
  • Serve as a social network for all participants desiring communication within the LTNP/HIV Controller community.
  • Disseminate pertinent information to all participants, i.e. specific reimbursement policies per research entity, legal rights, honorariums, etc.
  • Act as a ‘liaison’ between the participant and the research entities.
  • Educate and inform eligible and enrolled candidates about the clinical research study participation process.
  • Assist in ‘stream-lining’ all associated logistical issues pertaining to travel, lodging and transportation to destined research facilities.
  • Present a ‘unified’ voice of the participants to institutions conducting LTNP/HIV Controller research studies.
Del.icio.us     Digg This!     Facebook     Google     Reddit     Stumble It!
Last Updated ( Thursday, 26 February 2009 14:48 )

Please Donate!

Please make a tax deductible donation to Zephyr LTNP Foundation, a 501(c)(3) entity via Paypal. No Paypal account required.

CROI 2011

  • Wednesday 9th March 2011
    This is our final bulletin from CROI 2011. We hope you have found our news coverage useful. You can find all our coverage at www.aidsmap.com/croi2011, including the news reports and bulletins.We are always looking for ways of improving and developing our resources – so if you have any comments that you would like
  • Thursday 3rd March 2011
    There is increasing evidence of the transmission of HIV strains with resistance to anti-HIV drugs in low- and middle-income countries. Research in eleven sub-Saharan African countries showed that the chances of detecting transmitted resistance increased by over a third each year that a country had been scaling up HIV treatment. A separate study involving people recently diagnosed
  • Wednesday 2nd March 2011
    A new type of anti-HIV drug that targets the first step in HIV’s entry into cells has done well in a Phase IIa study. Currently known as BMS-663068, the drug was shown to be safe and to work against the virus. HIV cell entry is a three-step process. The virus must first attach to the

Follow Us

  • Facebook Page: zephyrfoundation.org
  • Twitter: zephyrfound
  • YouTube: zephyrfoundation

Controllers in Study

 Donation Thermometer
 Donation Thermometer
 Donation Thermometer

Our Goal:
December 30, 2009

Current Breakdown: 505 Elite Controllers 1009 Viremic Controllers 211 Other